ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.70
0.13%
US Tech 100
17,610.80
-0.01%
다우존스 지수
38,884.26
0.08%
Bitcoin
62,131.30
-0.33%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ARCA Biopharma Inc (ABIO)

  7. ARCA Biopharma Inc (ABIO) 뉴스

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ABIO
일자시간출처헤드라인심볼기업
2024/04/2605:15GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
2024/04/0602:09PR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
2024/04/0320:30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
2024/04/0320:30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
2024/02/0803:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
2024/02/0706:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2024/02/0206:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2024/02/0206:35GlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
2024/02/0206:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
2024/02/0108:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
2024/02/0106:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/12/2006:25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
2023/12/2006:20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
2023/12/2006:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
2023/12/0606:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/12/0506:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/10/1905:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/10/1905:25GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
2023/10/1905:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
2023/09/1205:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
2023/07/2205:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
2023/07/2205:25GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
2023/07/2205:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
2023/04/2505:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
 검색 관련기사 보기:NASDAQ:ABIO

최근 히스토리

FX
USDGBP
US Dollar vs Sterling
NASDAQ
QQQ
Invesco QQQ Trust Series 1
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
NYSE
KO
Coca Cola
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
CCOM
US100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유